Literature DB >> 24620027

Particle radiotherapy using protons or carbon ions for unresectable locally advanced head and neck cancers with skull base invasion.

Koichi Morimoto1, Yusuke Demizu, Naoki Hashimoto, Masayuki Mima, Kazuki Terashima, Osamu Fujii, Naoki Otsuki, Masao Murakami, Nobukazu Fuwa, Ken-Ichi Nibu.   

Abstract

OBJECTIVE: To study the oncological outcome of the patients with unresectable locally advanced primary head and neck cancers invading the skull base, treated with particle radiotherapy.
METHODS: Fifty-seven patients with unresectable primary head and neck cancers invading the skull base received proton or carbon ion radiotherapy as definitive treatment at Hyogo Ion Beam Medical Center between 2003 and 2009. Forty-seven patients were treated with proton radiotherapy and 10 patients were treated with carbon ion radiotherapy. A retrospective review was performed with clinical charts and recorded imagings.
RESULTS: With a median follow-up of 32 months, the 3-year actual survival and local progression-free rates of all the patients were 61 and 56%, respectively. The 3-year actual survival rates of adenoid cystic carcinoma, squamous cell carcinoma, olfactory neuroblastoma, adenocarcinoma and malignant melanoma were 83, 44, 75, 0 and 38%, respectively. The 3-year actual local control rates of adenoid cystic carcinoma, squamous cell carcinoma, olfactory neuroblastoma, adenocarcinoma and malignant melanoma were 63, 31, 83, 50 and 0%, respectively. Distant metastasis was observed in 13 of 25 patients in adenoid cystic carcinoma, two of 14 patients in squamous cell carcinoma, one of six patients with olfactory neuroblastoma, two of four patients with adenocarcinoma, three of four patients with malignant melanoma and two of three patients with undifferentiated carcinoma. Mucositis and dermatitis were seen as acute toxicities. The most common late toxicity was visual disorder. Grades 2, 3 and 4 visual disorders were observed in seven, five and two patients, respectively.
CONCLUSIONS: Proton and carbon ion radiotherapy resulted in satisfactory local control in patients with locally advanced unresectable primary head and neck cancers invading the skull base.

Entities:  

Keywords:  carbon ion; head and neck cancer; particle radiotherapy; proton; skull base

Mesh:

Year:  2014        PMID: 24620027     DOI: 10.1093/jjco/hyu010

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  17 in total

1.  Treatment outcome of ion beam therapy in eight patients with head and neck cancers.

Authors:  Jun-Ichi Ohkubo; Nobusuke Hohchi; Shoko Takeuchi; Shoji Ikezaki; Yasuhiro Kise; Hiroki Koizumi; Hideaki Suzuki
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-11       Impact factor: 2.503

2.  Reirradiation for recurrent head and neck cancers using charged particle or photon radiotherapy.

Authors:  Hideya Yamazaki; Yusuke Demizu; Tomoaki Okimoto; Mikio Ogita; Kengo Himei; Satoaki Nakamura; Gen Suzuki; Ken Yoshida; Tadayuki Kotsuma; Yasuo Yoshioka; Ryoongjin Oh
Journal:  Strahlenther Onkol       Date:  2017-04-19       Impact factor: 3.621

3.  Percutaneous Image-Guided Cryoablation of Head and Neck Tumors for Local Control, Preservation of Functional Status, and Pain Relief.

Authors:  Jeffrey P Guenette; Kemal Tuncali; Nathan Himes; Paul B Shyn; Thomas C Lee
Journal:  AJR Am J Roentgenol       Date:  2016-11-15       Impact factor: 3.959

Review 4.  Adenoid Cystic Carcinoma (ACC) Infiltrating the Skull Base: A Systematic Review of Clinical Characteristics and Management Strategies.

Authors:  Othman Bin-Alamer; Ali S Haider; Adhiraj Chaudhary; Kishore Balasubramanian; Tessa Breeding; Paolo Palmisciano; Maryam Haider; Aaron A Cohen-Gadol; Tarek Y El Ahmadieh; Kenny Yu
Journal:  Cancer Diagn Progn       Date:  2022-09-03

Review 5.  National Effort to Re-Establish Heavy Ion Cancer Therapy in the United States.

Authors:  Arnold Pompos; Robert L Foote; Albert C Koong; Quynh Thu Le; Radhe Mohan; Harald Paganetti; Hak Choy
Journal:  Front Oncol       Date:  2022-06-14       Impact factor: 5.738

6.  Complications in Salvage Surgery for Nasal and Paranasal Malignant Tumors Involving the Skull Base.

Authors:  Masanori Teshima; Hirotaka Shinomiya; Naoki Otsuki; Hidehito Kimura; Masaaki Taniguchi; Kazunobu Hashikawa; Eiji Kohmura; Ken-Ichi Nibu
Journal:  J Neurol Surg B Skull Base       Date:  2017-09-14

7.  Treatment Outcomes of Locally Advanced Squamous Cell Carcinoma of the Ethmoid Sinus Treated with Anterior Craniofacial Resection or Chemoradiotherapy.

Authors:  Takeharu Ono; Norimitsu Tanaka; Hirohito Umeno; Kiyohiko Sakata; Motohiro Morioka; Yoko Ohmaru; Hideaki Rikimaru; Noriyuki Koga; Kensuke Kiyokawa; Shun-Ichi Chitose; Buichiro Shin; Takeichiro Aso; Hidehiro Etoh; Toshi Abe
Journal:  Case Rep Oncol       Date:  2017-04-18

8.  Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma.

Authors:  Yi-Chan Lee; Ta-Jen Lee; Ngan-Ming Tsang; Yenlin Huang; Cheng-Lung Hsu; Li-Jen Hsin; Yi-Hsuan Lee; Kai-Ping Chang
Journal:  J Otolaryngol Head Neck Surg       Date:  2018-02-05

9.  Managing locally advanced adenoid cystic carcinoma of the head and neck during the COVID-19 pandemic crisis: Is this the right time for particle therapy?

Authors:  Sara Ronchi; Barbara Vischioni; Maria Bonora; Amelia Barcellini; Laura D Locati; Paolo Castelnuovo; Piero Nicolai; Cesare Piazza; Mohssen Ansarin; Marco Benazzo; Ester Orlandi
Journal:  Oral Oncol       Date:  2020-05-14       Impact factor: 5.337

10.  Accelerated Hypofractionated Active Raster-Scanned Carbon Ion Radiotherapy (CIRT) for Laryngeal Malignancies: Feasibility and Safety.

Authors:  Sati Akbaba; Kristin Lang; Thomas Held; Olcay Cem Bulut; Matthias Mattke; Matthias Uhl; Alexandra Jensen; Peter Plinkert; Stefan Rieken; Klaus Herfarth; Juergen Debus; Sebastian Adeberg
Journal:  Cancers (Basel)       Date:  2018-10-18       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.